Interestingly, the two AML cases associated with the NPM1 genetic anomaly (deletion or recurrent mutations) presented a remarkable increase in the fraction of mature and hypermature NK cells in the detriment of immature cells, accompanied by the highest expressions of CD159a- and CD158a-positive hypermature NK cells. This evidence concerns the gene KIR2DL1 and acute myeloid leukemia.